Another regulator of BA composition, CYP8B1 (an 12α-hydroxylase) has been reported to contribute to metabolic anomalies in T2DM as greater 12α-hydroxy/non12α-hydroxy BA ratios are correlated with decreased insulin sensitivity (93). Here, INS is linked to type 2 diabetes mellitus.